Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Patients are tired of shocking medical bills they didn’t expect and can’t afford.
Do they tackle drugs with extremely high costs taken by a handful of patients, or drugs with merely very high costs taken by a larger group?
West Virginia’s lawsuit against Janssen and others arrives amid a rise in HIV, hepatitis and overdose rates linked to the opioid crisis.
The funding, which also supports harm reduction, arrives from the NY attorney general’s settlements with opioid manufacturers.
There is really no “free” Hep C treatment: Someone always pays.
Stop me if you’ve heard this one before.
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.
U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”
Puerto Rico’s main exports are medical devices and pharmaceuticals, including HIV and cancer drugs.
He also told pharma leaders: “We have to get prices down. We have no choice.”
Report by HIV and hepatitis C advocates gives lawmakers and the White House a 100-day road map to tackling drug costs.
Last month, 35 states and the District of Columbia sued the makers of this popular medication-assisted treatment in a federal court probe.
Massachusetts is the latest state to lift restrictions on hepatitis C virus (HCV) treatment under its Medicaid program.
The hepatitis C pipeline: huge changes on the horizon
Pharmasset has announced plans to amend one of its Phase II clinical trials in the wake of liver toxicity concerns among some volunteers
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.